Pampa Metals Begins Trading on the OTCQB(R) Market and Announces DTC Eligibility of Its Common Shares in the United States
VANCOUVER, BC / ACCESSWIRE / May 7, 2021 / Pampa Metals Corp. (CSE:PM)(FSE:FIRA)(OTC PINK:PMMCF) (“Pampa…
VANCOUVER, BC / ACCESSWIRE / May 7, 2021 / Pampa Metals Corp. (CSE:PM)(FSE:FIRA)(OTC PINK:PMMCF) (“Pampa…
Pilot project includes point-of-care sample collection, PCR processing and final testing of workflow logistics Project…
Business Continuity and IT Disaster Recovery specialist acquires enterprise backup expert 4sl Databarracks has acquired…
NEW YORK and LONDON, May 07, 2021 (GLOBE NEWSWIRE) — Tiziana Life Sciences plc (NASDAQ:…
COPENHAGEN, Denmark, May 7, 2021 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today…
May 7, 2021 Breda, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology…
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN ANY JURISDICTION IN WHICH IT WOULD BE UNLAWFUL…
Orphazyme A/SCompany announcementNo. 14/2021Inside informationCompany Registration No. 32266355 Pivotal trial did not meet primary and secondary endpoints evaluating…
Oslo (Norway), 7 May 2021 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company,…
REGULATED INFORMATION Preliminary documents for the Annual General Meeting have been made available on company’s…
BOSTON and LOUISVILLE, Ky., May 06, 2021 (GLOBE NEWSWIRE) — Talaris Therapeutics, Inc., a late-clinical…
FLORHAM PARK, N.J., May 06, 2021 (GLOBE NEWSWIRE) — Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a…
CHARLESTON, S.C., May 06, 2021 (GLOBE NEWSWIRE) — Today, Efferent Labs announces an expanded development…
CANTON, Mass., May 06, 2021 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading…
Acquisition of Zikani Therapeutics, Ribosomal Modulation Company; Combined Company Advancing Ribosomal RNA-Targeted Genetic Therapies Additional…
BELTSVILLE, Md., May 06, 2021 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical…
Webcast Today at 4:30 pm Eastern Time SOUTH SAN FRANCISCO, May 06, 2021 (GLOBE NEWSWIRE)…
Enrollment ongoing in three Cellectis-sponsored Phase 1 dose-escalation clinical studies BALLI-01 in r/r B-ALL patients,…
PRINCETON, N.J., May 06, 2021 (GLOBE NEWSWIRE) — Certara, Inc. (Nasdaq: CERT), a global leader…
Net Revenue of $2.7 Million; Highest First Quarter in Company History SOUTH ORANGE, NJ, May…